OR WAIT null SECS
© 2021 MJH Life Sciences and Nutritional Outlook. All rights reserved.
© 2021 MJH Life Sciences™ and Nutritional Outlook. All rights reserved.
January 13, 2021
The agreement is for the development of pharmaceutical therapies for brain and eye health based on Aker’s Lysoveta LPC-bound EPA and DHA.
January 06, 2021
As part of their collaboration, Aker has entered into an exclusive licensing agreement with University of Illinois Chicago for the current intellectual property resulting from the University's work on LPC-bound EPA and DHA.
December 18, 2020
Epax was awarded a $900,000 grant from the Norwegian Research Council to research the potential of new fatty acids for human health over the next four years.
December 15, 2020
A new study published by the Fatty Acid Research Institute in conjunction with The Cooper Institute sheds some new light on how omega-3 fatty acids may support heart health.
December 07, 2020
Dosecann launched a precision-dosed cannabinoid product featuring Ahiflower and Lonza's Licaps Capsugel capsules for the Canadian medical cannabis space.
December 01, 2020
Aker BioMarine has developed a pilot product and production method for lysophosphatidylcholine (LPC) – bound EPA and DHA from krill
November 19, 2020
NOW released a new report on alpha lipoic acid (ALA), its fifth report in 2020 regarding suspect brands whose main sales appear to be on Amazon.
November 18, 2020
Algarithm Ingredients has launched a new line of algal omega-3 concentrates called thetamega3 for the North American market.
November 04, 2020
The wellness industry faces a double-edged sword: its products have never been more popular, but production hurdles have never been higher.
October 20, 2020
The Council for Responsible Nutrition released detailed results of its latest consumer surveys on U.S. dietary supplement usage in 2020 during its virtual “NOW, NEW, NEXT” conference last week.